BCL2 and neoplasm: The BIM deletion polymorphism involves a 2903-bp deletion that results in the loss of the pro-apoptotic BCL2 homology domain 3 (BH3) in BIM isoforms, thereby inhibiting tumor cell apoptosis (22).